Clinical Trial

Molecular and Morphologic Characterization of Circulating Endothelial Cells

Study acronym: CEC
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The primary hypothesis of this study is that circulating endothelial cells (CECs) harbor key genetic and structural characteristics predisposing individuals to acute atherosclerotic plaque rupture and heart attack.
Protocol Amendment History 15 amendments
This ClinicalTrials.gov record has been amended 15 times since 2009-10-30; most recent amendment 2025-01-15.
Status change: Enrolling by Invitation → Active, Not Recruiting 2017-05-02
Status change: Recruiting → Enrolling by Invitation 2016-11-21
Status change: Not Yet Recruiting → Recruiting 2010-03-12
Trial Details
NCT Number NCT01005485
Lead Sponsor Scripps Translational Science Institute
Conditions Acute Myocardial Infarction
Enrollment 664 participants
Start Date 2010-01
Primary Completion 2017-04 (estimated)
Study Completion 2025-12 (estimated)
Updated on ClinicalTrials.gov 2025-01-17